Report Code: TIPRE00019345 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Medicine Market - By Type
1.3.2 Medicine Market - By End User
1.3.3 Medicine Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MEDICINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.3. EXPERT OPINIONS
5. MEDICINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MEDICINE MARKET - GLOBAL MARKET ANALYSIS
6.1. MEDICINE - GLOBAL MARKET OVERVIEW
6.2. MEDICINE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. MEDICINE MARKET - REVENUE AND FORECASTS TO 2028 – TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. BRAND DRUGS
7.3.1. Overview
7.3.2. Brand Drugs Market Forecast and Analysis
7.4. GENERIC DRUGS
7.4.1. Overview
7.4.2. Generic Drugs Market Forecast and Analysis
8. MEDICINE MARKET - REVENUE AND FORECASTS TO 2028 – END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL
8.3.1. Overview
8.3.2. Hospital Market Forecast and Analysis
8.4. CLINIC
8.4.1. Overview
8.4.2. Clinic Market Forecast and Analysis
8.5. OTHER
8.5.1. Overview
8.5.2. Other Market Forecast and Analysis
9. MEDICINE MARKET REVENUE AND FORECASTS TO 2028 – GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Medicine Market Overview
9.1.2 North America Medicine Market Forecasts and Analysis
9.1.3 North America Medicine Market Forecasts and Analysis - By Type
9.1.4 North America Medicine Market Forecasts and Analysis - By End User
9.1.5 North America Medicine Market Forecasts and Analysis - By Countries
9.1.5.1 United States Medicine Market
9.1.5.1.1 United States Medicine Market by Type
9.1.5.1.2 United States Medicine Market by End User
9.1.5.2 Canada Medicine Market
9.1.5.2.1 Canada Medicine Market by Type
9.1.5.2.2 Canada Medicine Market by End User
9.1.5.3 Mexico Medicine Market
9.1.5.3.1 Mexico Medicine Market by Type
9.1.5.3.2 Mexico Medicine Market by End User
9.2. EUROPE
9.2.1 Europe Medicine Market Overview
9.2.2 Europe Medicine Market Forecasts and Analysis
9.2.3 Europe Medicine Market Forecasts and Analysis - By Type
9.2.4 Europe Medicine Market Forecasts and Analysis - By End User
9.2.5 Europe Medicine Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Medicine Market
9.2.5.1.1 Germany Medicine Market by Type
9.2.5.1.2 Germany Medicine Market by End User
9.2.5.2 France Medicine Market
9.2.5.2.1 France Medicine Market by Type
9.2.5.2.2 France Medicine Market by End User
9.2.5.3 Italy Medicine Market
9.2.5.3.1 Italy Medicine Market by Type
9.2.5.3.2 Italy Medicine Market by End User
9.2.5.4 Spain Medicine Market
9.2.5.4.1 Spain Medicine Market by Type
9.2.5.4.2 Spain Medicine Market by End User
9.2.5.5 United Kingdom Medicine Market
9.2.5.5.1 United Kingdom Medicine Market by Type
9.2.5.5.2 United Kingdom Medicine Market by End User
9.2.5.6 Rest of Europe Medicine Market
9.2.5.6.1 Rest of Europe Medicine Market by Type
9.2.5.6.2 Rest of Europe Medicine Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Medicine Market Overview
9.3.2 Asia-Pacific Medicine Market Forecasts and Analysis
9.3.3 Asia-Pacific Medicine Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Medicine Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Medicine Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Medicine Market
9.3.5.1.1 Australia Medicine Market by Type
9.3.5.1.2 Australia Medicine Market by End User
9.3.5.2 China Medicine Market
9.3.5.2.1 China Medicine Market by Type
9.3.5.2.2 China Medicine Market by End User
9.3.5.3 India Medicine Market
9.3.5.3.1 India Medicine Market by Type
9.3.5.3.2 India Medicine Market by End User
9.3.5.4 Japan Medicine Market
9.3.5.4.1 Japan Medicine Market by Type
9.3.5.4.2 Japan Medicine Market by End User
9.3.5.5 South Korea Medicine Market
9.3.5.5.1 South Korea Medicine Market by Type
9.3.5.5.2 South Korea Medicine Market by End User
9.3.5.6 Rest of Asia-Pacific Medicine Market
9.3.5.6.1 Rest of Asia-Pacific Medicine Market by Type
9.3.5.6.2 Rest of Asia-Pacific Medicine Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Medicine Market Overview
9.4.2 Middle East and Africa Medicine Market Forecasts and Analysis
9.4.3 Middle East and Africa Medicine Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Medicine Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Medicine Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Medicine Market
9.4.5.1.1 South Africa Medicine Market by Type
9.4.5.1.2 South Africa Medicine Market by End User
9.4.5.2 Saudi Arabia Medicine Market
9.4.5.2.1 Saudi Arabia Medicine Market by Type
9.4.5.2.2 Saudi Arabia Medicine Market by End User
9.4.5.3 U.A.E Medicine Market
9.4.5.3.1 U.A.E Medicine Market by Type
9.4.5.3.2 U.A.E Medicine Market by End User
9.4.5.4 Rest of Middle East and Africa Medicine Market
9.4.5.4.1 Rest of Middle East and Africa Medicine Market by Type
9.4.5.4.2 Rest of Middle East and Africa Medicine Market by End User
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. MEDICINE MARKET, KEY COMPANY PROFILES
11.1. PFIZER INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. GLAXOSMITHKLINE PLC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ASTRAZENECA PLC
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. NOVARTIS AG
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ELI LILLY AND COMPANY
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SANOFI S.A.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. ALLERGAN, INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. F. HOFFMANN-LA ROCHE AG
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. MERCK AND CO., INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS